Recently, evidence linking mGluR5 to AD pathophysiology, as well as MDD, has been provided [9], but changes in mGluR5 expression in the brains of AD patients and animal models remain controversial [10,11,12,13,14]. Here, GRM5 is linked to Alzheimer disease.